SAN DIEGO, June 20, 2023 /PRNewswire/ Cardiff Oncology, Inc. , a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies. | June 20, 2023
My sister Seema has a penchant for following my recipes and also for changing them to suit her tastes and whims, often with excellent results. This recipe is a